Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
37,115
Sort by:
2017 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 31,950.00
... : - Blood Centers Plasma Fractionation Facilities Hospitals Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review of automated and semi-automated molecular and immunohematology analyzers.Technology ...
March 2017
775 pages
2017 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 17,730.00
... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...
March 2017
820 pages
2017 Clinical Chemistry and Immunodiagnostic Markets: Analysis of Emerging Tests and Strategic Profiles of Leading Suppliers
US$ 3,150.00
... 320-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused ... also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing ...
March 2017
320 pages
2017 Therapeutic Drug Monitoring (TDM) Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 7,650.00
... from VPGMarketResearch contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales ... . The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key ...
March 2017
313 pages
2017 Italy Hospital Clinical Chemistry and Immunodiagnostic Markets
US$ 3,465.00
... a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as well ... forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Italian hospitals, including controls, calibrators and ...
March 2017
521 pages
2017 Immunoprotein Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 7,650.00
... global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report provides test volume ... trends in the U.S., Europe, Japan; provides test volume and sales forecasts by country, market segment and individual test; compares features of leading analyzers; and profiles ...
March 2017
297 pages
2017 Drugs of Abuse Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 7,650.00
... provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading ... and market segment for the following assays: AmphetaminesAntidepressantsBarbituratesBenzodiazepinesCannabinoids/MarijuanaCocaineLSDMethadoneMethaqualoneOpiatesPhencyclidine (PCP)Propoxphene During the next decade, the abused drug testing market will undergo ...
March 2017
318 pages
2017 Europe Drugs of Abuse Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 5,850.00
... -page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...
March 2017
300 pages
2017 Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 4,905.00
... malignancy assays and the rapid market expansion worldwide.This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany ... test volume and sales forecasts by country and market segment.The report also examines market applications of DNA probes, biochips/microarrays, monoclonal ...
March 2017
257 pages
2017 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 4,815.00
... technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ... report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ...
March 2017
120 pages
2017 Coagulation Reagent and Instrument Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 31,050.00
... coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation ... characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers ...
March 2017
650 pages
2017 Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 33,750.00
... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Antidepressants. Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison ...
March 2017
1200 pages
